Halozyme Therapeutics Price Chart
Halozyme Therapeutics Volume Chart
Halozyme Therapeutics Market Segments
After Hours
+0.00(+0.00%)
| Open | $64.49 |
|---|---|
| Close | $64.49 |
| Low | $61.64 |
| Low Change | -2.86 (-4.43%) |
| High | $64.49 |
| High Change | +0.00 (+0.00%) |
| Range | $2.86 |
| Volume | 208.293K |
| Dollar Volume | $13.43M |
Regular Trading Hours
+0.30(+0.46%)
| Open | $64.22 |
|---|---|
| Close | $64.52 |
| Low | $63.61 |
| Low Change | -0.61 (-0.95%) |
| High | $65.65 |
| High Change | +1.43 (+2.23%) |
| Range | $2.04 |
| Volume | 1.011M |
| Dollar Volume | $65.20M |
Premarket
+0.00(+0.00%)
| Open | $65.00 |
|---|---|
| Close | $65.00 |
| Low | $65.00 |
| Low Change | 0.00 (0.00%) |
| High | $65.00 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 2.261K |
| Dollar Volume | $146.97K |
After Hours Yesterday
+0.00(+0.00%)
| Open | $65.40 |
|---|---|
| Close | $65.40 |
| Low | $65.11 |
| Low Change | -0.29 (-0.44%) |
| High | $65.40 |
| High Change | +0.00 (+0.00%) |
| Range | $0.29 |
| Volume | 396.706K |
| Dollar Volume | $25.94M |
Regular Trading Hours Yesterday
+0.21(+0.32%)
| Open | $65.14 |
|---|---|
| Close | $65.35 |
| Low | $64.46 |
| Low Change | -0.68 (-1.04%) |
| High | $66.00 |
| High Change | +0.86 (+1.32%) |
| Range | $1.54 |
| Volume | 1.164M |
| Dollar Volume | $76.07M |
Premarket Yesterday
+0.00(+0.00%)
| Open | $65.00 |
|---|---|
| Close | $65.00 |
| Low | $64.10 |
| Low Change | -0.90 (-1.38%) |
| High | $65.00 |
| High Change | +0.00 (+0.00%) |
| Range | $0.90 |
| Volume | 613 |
| Dollar Volume | $39.85K |
Halozyme Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $63.65 |
|---|---|
| 10 Day Moving Average (SMA10) | $63.31 |
| 20 Day Moving Average (SMA20) | $64.32 |
| 50 Day Moving Average (SMA50) | $69.87 |
| 100 Day Moving Average (SMA100) | $69.30 |
| 200 Day Moving Average (SMA200) | $67.14 |
Halozyme Therapeutics Statistics
| Average Volume (30 Days) | 1.63M |
|---|---|
| P/E Ratio (Current) | 24.49 |
| EPS (Current) | $2.67 |
| Dividend Yield | 0.00% |
| Free Cash Flow | $644.59M |
| Cash Ratio | 0.76 |
| Current Ratio | 4.66 |
| Quick Ratio | 3.66 |
| Debt to Equity | 43.89 |
| Enterprise Value | $9.76B |
| EV to EBITDA | 10.96 |
| EV to Sales | 6.99 |
| Price to Book | 158.73 |
| Price to Cash Flow | 11.89 |
| Price to Free Cash Flow | 12.02 |
| Price to Sales | 5.55 |
| Return on Assets | 0.13% |
| Return on Equity | 6.49% |
Halozyme Therapeutics Stock Splits
There have been no stock splits for Halozyme Therapeutics (HALO).
Halozyme Therapeutics Dividends
There have been no dividends for Halozyme Therapeutics (HALO).